TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters TeleDaaS™ Launches Y90 Treatment Planning Service and Announces Pilot Program for Early Adopters

TeleDaaS™ Launches as Premier Provider of Dosimetry as a Service for Clinical Research Organizations TeleDaaS revolutionizes radiopharmaceutical research by delivering highly-scalable, clinical-grade dosimetry to accelerate cancer treatment breakthroughs.